Iron depletion by whole-blood donation harms menstruating females: The current whole-blood-collection paradigm needs to be changed

Transfusion

Volumn 46, Issue 10, 2006, Pages 1667-1681

  Newman, Bruce ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BILE ACID SEQUESTRANT; CARBONYL IRON; CHLORAMPHENICOL; CIMETIDINE; DIMERCAPROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETIDRONIC ACID; FERRITIN; FERRO SANOL DUODENAL; FERROUS ION; FERROUS SULFATE; HEMOGLOBIN; IRON; LEVODOPA; LEVOTHYROXINE; METHYLDOPA; PENICILLAMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; ZINC;

ALLERGIC REACTION; ATHEROSCLEROSIS; BLOOD DONOR; CLINICAL TRIAL; COGNITIVE DEFECT; COLON CANCER; COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG PACKAGING; ENDURANCE; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; FOOD DRUG INTERACTION; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN SYNTHESIS; HIGH RISK POPULATION; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON OVERLOAD; IRON THERAPY; MASS SCREENING; MENSTRUATION; NOTE; PHYSICAL STRESS; PREGNANCY; RESTLESS LEGS SYNDROME; RISK BENEFIT ANALYSIS; RISK FACTOR; WORK CAPACITY;

ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD DONORS; FEMALE; HEMOGLOBINS; HUMANS; IRON; IRON, DIETARY; MENSTRUATION;

EID: 33748930284     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00969.x     Document Type: Note

References (150)

1. International Forum. The hippocratian principle of 'primum nil nocere' demands that the metabolic state of a donor should be normalized prior to a subsequent donation of blood or plasma. How much blood, relative to his body weight, can a donor give over a certain period, without a continuous deviation of iron metabolism in the direction of iron deficiency? Vox Sang 1981;41:336-43.
2. Skikne B, Lynch S, Borek D, Cook J. Iron and blood donation. Clin Haematol 1984, 271-87.
3. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the US population. Blood 1986;68:726-31.
4. Looker AC, Dallman PR, Carroll MS, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997;277:973-6.
5. Beutler E, Larsh SE, Gurney CW. Iron therapy in chronically fatigued, nonanemic women: a double-blind study. Ann Intern Med 1960;52:378-94.
6. Haas J, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001;131:676S-690S.
7. Li R, Chen X, Yan H, et al. Functional consequences of iron supplementation in iron deficient female cotton workers in Beijing, China. Am J Clin Nutr 1994;59:908-13.
8. Verdon F, Burnand B, Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anemic women: double blind randomized placebo controlled trial. Br Med J 2003;326:1124-6.
9. Patterson AJ, Brown WJ, Powers JR, Roberts DC. Iron deficiency, general health and fatigue: results from the Australian longitudinal study on women's health. Qual Life Res 2000;9:491-7.
10. Rangan AM, Blight GD, Binns CW. Iron status and non-specific symptoms of female students. J Am Coll Nutr 1998;17:351-5.
11. Patterson AJ, Brown WJ, Roberts DC. Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J Am Coll Nutr 2001;20:337-42.
12. Morrow JJ, Dagg JH, Goldberg A. A controlled trial of iron therapy in sideropenia. Scott Med J 1968;13:78-83.
13. Elwood PC, Hughes D. Clinical trial of iron therapy on psychomotor function in anaemic adolescents. Br Med J 1970;3:254-5.
14. Fordy J, Benton D. Does low iron status influence psychological functioning? J Hum Nutr Diet 1994;7:127-33.
15. Duport N, Preziosi P, Boutron-Ruault MC, et al. Consequences of iron depletion on health in menstruating women. Eur J Clin Nutr 2003;57:1169-75.
16. Brownlie T, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004;79:437-43.
17. Brownlie T, Utermohlen V, Hinton PS, Giordano C, Haas JD. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 2002;75:734-42.
18. Hinton PS, Giordano C, Brownlie T, Haas JD. Iron supplementation improves endurance after training in iron-depleted, non-anemic women. J Appl Physiol 2000;88:1103-11.
19. Zhu YI, Haas JD. Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial. J Appl Physiol 1998;84:1768-75.
20. 2max, endurance, and blood lactate in women. Med Sci Sports Exer 1993;25:1386-92.
21. Rowland TW, Deisroth MB, Green GM, Kelleher JF. The effect of iron therapy on the exercise capacity of nonanemic iron-deficient adolescent runners. Am J Dis Child 1988;142:165-9.
22. Klingshirn LA, Pate RR, Bourque SP, Davis M, Sargent RG. Effect of iron supplementation on endurance capacity in iron depleted female runners. Med Sci Sports Exer 1992;24:819-24.
23. 2 transport at rest, submaximal and maximal work. J Appl Physiol 1978;44:36-43.
24. Davies CT, Chukweumeka AC, Van Haaren JP. Iron-deficiency anemia: its effect on maximum aerobic power in responses exercise in African males aged 17-40 years. Clin Sci (Lond) 1973;44:555-62.
25. Gardner GW, Edgerton VR, Senewiratne B, Barnard RJ, Ohira Y. Physical work capacity and metabolic stress in subjects with iron-deficiency anemia. Am J Clin Nutr 1977;30:910-7.
26. Ohira Y, Edgerton VR, Gardner GW, et al. Work capacity, heart rate and blood lactate responses to iron treatment. Br J Haematol 1979;41:365-72.
27. Edgerton VR, Ohira Y, Hettiarachchi J, et al. Elevation of hemoglobin and work tolerance in iron-deficient subjects. J Nutr Sci Vitaminol (Tokyo) 1981;27:77-86.
28. Edgerton VR, Gardner GW, Ohira Y, Gunawardena KA, Senewiratne B. Iron-deficiency anemia and its effect on worker productivity and activity patterns. Br Med J 1979;2:1546-9.
29. Silber MH, Richardson JW. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 2003;78:52-4.
30. Ufberg J, Nystrom B. Restless legs syndrome in blood donors. Sleep Med 2004;5:115-8.
31. Kryger MH, Sheperetycky M, Foerster J, Manfreda J. Sleep disorders in repeat blood donors. Sleep 2003;26:625-6.
32. Trenkwalder C, Paulus C, Walters AS. The restless leg syndrome [review]. Lancet Neurol 2005;4:465-75.
33. Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med 2004;5:293-9.
34. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21:371-7.
35. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;23:200-3.
36. Krieger J, Schroeder C. Iron, brain and restless legs syndrome. Sleep Med Rev 2001;5:277-86.
37. Ondo WG. Restless leg syndrome [review]. Curr Neurol Neurosci Rep 2005;5:266-74.
38. Klebanoff MA, Shiono PH, Selby JV, Trachtenberg AI, Graubard BI. Anemia and sponteneous preterm birth. Am J Obstet Gynecol 1991;164:59-63.
39. Murphy JF, O'Riordan J, Newcombe RG, Coles EC, Pearson JF. Relation of haemoglobin levels in first and second trimester to outcome of pregnancy. Lancet 1986;1:992-5.
40. Scholl TO, Hediger ML, Fischer RL, Shearer JW. Anemia vs. iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr 1992;55:985-8.
41. Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr 1994;59:492S-501S.
42. Zhou LM, Yang WW, Hua JZ, et al. Relation of hemoglobin measured at different times in pregnancy to preterm birth and low birth weight in Shanghai, China. Am J Epidemiol 1998;148:998-1006.
43. Scholl TO, Reilly T. Anemia, iron and pregnancy outcome. Am J Clin Nutr 2000;130(Suppl):443S-7S.
44. Garn SM, Keating MT, Falkner F. Hematologic status and pregnancy outcomes. Am J Clin Nutr 1981;34:115-7.
45. Steer P, Alam MA, Wadsworth J, Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. Br Med J 1995;310:489-91.
46. Rasmussen KM. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality. J Nutr 2001;131:590S-603S.
47. Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005;81(Suppl):1218S-22S.
48. Scanlon KS, Yip R, Schieve LA, Cogswell ME. High and low hemoglobin levels during pregnancy: differential risks for preterm birth and small for gestational age. Obstet Gynecol 2000;96:741-8.
49. Beard JL, Murray-Kolb LE, Perez E, et al. Iron status alters cognitive and behavioral functioning in women during reproductive years [abstract]. International Nutritional Anemia Consultative Group (INACG) Symposium. Feb. 6, 2003, Marrakech, Morocco.
50. Murray-Kolb LE, Whitfield KE, Beard JE. Iron status alters cognitive functioning women during reproductive years [abstract]. Experimental Biology 2004 meeting. 2004 Apr 17-21; Washington, DC.
51. Beard J. Iron deficiency alters brain development and functioning. J Nutr 2003;133:1468S-72S.
52. Bruner AB, Joffe A, Duggan AK, et al. Randomised study of cognitive effect of iron supplementation in non-anaemic iron deficient adolescent girls. Lancet 1996;348:992-6.
53. Ballin A, Berar M, Rubenstein, et al. Iron state in female adolescents. Am J Dis Child 1992;146:803-5.
54. Groner JA, Holtzman NA, Charney E, Mellits ED. A randomized trial of oral iron on tests of short-term memory and attention span in young pregnant women. J Adolesc Health Care 1986;7:44-8.
55. Beard JL, Hendricks MK, Perez EM, et al. Maternal iron-deficiency anemia affects postpartum emotions and cognition. J Nutr 2005;135:267-72.
56. Perez EM, Hendricks MK, Beard JL, et al. Mother-infant interactions and infant development are altered by maternal iron-deficiency anemia. J Nutr 2005;135:850-5.
57. Recommendations to prevent and control iron-deficiency anemia in the United States. MMWR Morb Mortal Wkly Rep 1998;47:1-29.
58. Iron deficiency - United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2002;51:897-89.
59. Siegfried B, Newman B. The donor weight distribution in a sample of blood drives [abstract]. Transfusion 2005;45 (Suppl):88A.
60. Newman B, Pichette S, Pichette D, Dzaka E. Adverse effects in blood donors after whole blood donation: a study of 1,000 blood donors interviewed three weeks after whole blood donation. Transfusion 2003;43:598-603.
61. Garry PJ, Koehler KM, Simon TL. Iron stores and iron absoption: effects of repeated blood donations. Am J Clin Nutr 1995;62:611-20.
62. Garry PJ, Vanderjagt DJ, Wayne SJ, et al. A prospective study of blood donations in healthy elderly person. Transfusion 1991;31:686-92.
63. Punnonen K, Rajamaki A. Evaluation of iron status of Finish blood donors using serum transferrin receptor. Transfus Med 1999;9:131-4.
64. Milman N, Sondergaard M. Iron stores in male blood donors evaluated by serum ferritin. Transfusion 1984;24:464-8.
65. Milman N, Kirchoff M. Influence of blood donation on iron stores assessed by serum ferritin and haemoglobin in a population survey of 1433 Danish males. Eur J Haematol 1991;47:134-9.
66. Raftos J, Schuller M, Lovric VA. Iron stores assessed in blood donors by hematofluorometry. Transfusion 1983;23:226-8.
67. Simon TL, Garry PJ, Hooper EM. Iron stores in blood donors. JAMA 1981;245:2038-43.
68. Pederson NS, Morling N. Iron stores in blood donors evaluated by serum ferritin. Scand J Haematol 1978;20:70-6.
69. Finch CA, Cook JD, Labbe RF, Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977;50:441-7.
70. Nilsson SB, Berlin R. Iron state in regular blood donors. Scand J Haematol 1973;11:342-9.
71. Conrad ME, Crosby WH. The natural history of iron deficiency induced by phlebotomy. Blood 1962;20:173-85.
72. Birgegard G, Hogman C, Killander A, Wide L. Serum ferritin levels in male blood donors: relation to number of phlebotomies and iron supplementation. Vox Sang 1978;34:65-70.
73. Jacob RA, Sandstead HH, Klevay LM, Johnson LK. Utility of serum ferritin as a measure of iron deficiency in normal males undergoing repetitive phlebotomy. Blood 1980;56:786-91.
74. Hagberg B, Wallenius G, Wranne L. Latent iron deficiency after repeated removal of blood in blood donors. Scand J Clin Lab Invest 1958, 63-6.
75. Simon TL, Hunt WC, Garry PJ. Iron supplementation for menstruating female blood donors. Transfusion 1984;24:469-72.
76. Fowler WM, Barer AP. Rate of hemoglobin regeneration in blood donors. JAMA 1942;118:421-7.
77. Barer AP, Folwer WM. The effect of iron on the hemoglobin regeneration in blood donors. Am J Med Sci 1943;205:9-16.
78. Lieden G. Iron state in regular blood donors. Scand J Haematol 1973;11:342-9.
79. Finch S, Haskins D, Finch CA. Iron metabolism: hematopoiesis following phlebotomy: iron as a limiting factor. J Clin Invest 1950;29:1078-86.
80. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990;75:1870-6.
81. Punnonen Irjaia K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-7.
82. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-64.
83. Newman BH, Roth AJ. Estimating the probability of a blood donation adverse event based on 1000 interviewed whole-blood donors. Transfusion 2005;45:1715-21.
84. Newman BH, Newman DT, Ahmad R, Roth AJ. The effect of whole-blood donor adverse events on blood donor return rates. Transfusion 2006;46:1374-9.
85. Walters AS. Toward a better definition of restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-42.
86. Allen RP, Hening WA, Montplaisir J, et al. Restless legs syndrome; diagnostic criteria, special considerations and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19.
87. Montplaisir J, Boucher S, Poirier, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-5.
88. Garcia-Borreguero D, Odin P, Schwarz C. Restless legs syndrome. an overview of the current understanding and management [review]. Acta Neurol Scand 2004;109:303-17.
89. Rothdach AJ, Trenkwalder C, Haberstock J, Kreil U, Berger K. Prevalence and risk factors of restless leg syndrome in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000;54:1064-8.
90. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196-202.
91. Ulfberg J, Nystrom B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001;46:17-9.
92. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLG) [review]. Sleep Med 2004;5:385-91.
93. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18-64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16:1159-63.
94. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-5.
95. Boyer PJ, Ondo WG, Allen RP, et al. Neuropathologic evaluation of the central nervous system in restless legs syndrome: case report and review of literature. New Orleans: Society for Neuroscience; 2000.
96. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-700.
97. Earley C, Heckler D, Allen RP. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med 2005;6:301-5.
98. Nordlander NB. Therapy in restless legs. Acta Med Scand 1953;145:453-7.
99. Wood EM, Kim DM, Miller JP. Accuracy of predonation Hct sampling affects donor safety, eligibility, and deferral rates. Transfusion 2001;41:353-9.
100. Avoy DR, Canuel ML, Otton BM, Mileski EB. Hemoglobin screening in prospective blood donors: a comparison of methods. Transfusion 1977;17:261-4.
101. Coburn TJ, Miller WV, Parrill WD. Unacceptable variability of hemoglobin estimation on samples obtained from ear punctures. Transfusion 1977;17:265-8.
102. Patterson AJ, Brown WJ, Roberts DC, Seldon MR. Dietary treatment of iron deficiency in women of childbearing age. Am J Clin Nutr 2001;74:650-6.
103. Heath AL, Skeaff CM, O'Brien SM, Williams SM, Gibson RS. Can dietary treatment of non-anemic iron deficiency improve iron status? J Am Coll Nutr 2001;20:477-84.
104. Lieden G. Iron supplement to blood donors. I. Trials with intermittent iron supply. Acta Med Scand 1975;197:31-6.
105. Lieden G, Sverker H, Ehn L. Iron supplement to blood donors. II. Effect of continuous supply. Acta Medical Scand 1975:37-41.
106. Birgegard G, Hogman C, Johansson A, et al. Serum ferritin in the regulation of iron therapy in blood donors. Vox Sang 1980;38:29-35.
107. Gordeuk VR, Brittenham GM, McLaren C, Hughes MA, Keating LJ. Carbonyl iron therapy for iron-deficiency anemia. Blood 1986;67:745-52.
108. Gordeuk VR, Brittenham GM, Hughes M, Keating LJ, Opplt JJ. High-dose carbonyl iron for iron-deficiency anemia: a randomized double-blind trial. Am J Clin Nutr 1987;46:1029-34.
109. Gordeuk VR, Brittenham GM, Hughes MA, Keating LJ. Carbonyl iron for short-term supplementation in female blood donors. Transfusion 1987;27:80-5.
110. Gordeuk VR, Brittenham GM, Bravo J, Hughes MA, Keatong LJ. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion 1990;30:239-45.
111. Borch-Johnsen B, Halvorsen R, Stenberg V, Flesland O, Mowinckel P. The effect of daily low-dose iron supplements in female blood donors with depleted iron stores: comparison with female non-donors. Scand J Clin Lab Invest 1993;53:789-91.
112. Alvarez-Ossorio L, Kirchner H, Kluter H, Schlenke P. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med 2000;10:107-12.
113. Bianco C, Brittenham G, Gilcher RO, et al. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002;42:798-805.
114. Bier-Ulrich AM, Haubelt H, Anders C, et al. The impact of intensive serial plasmapheresis and iron supplementation on iron metabolism and hemoglobin concentration in menstruating women: a prospective randomized placebo-controlled double-blind study. Transfusion 2003;43:405-10.
115. Radtke H, Tegtmeier J, Rocker L, Salama A, Kiesewetter H. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004;44:1427-32.
116. Radtke H, Mayer B, Rocker L, Salama A, Kiesewetter H. Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study. Transfusion 2004;44:1463-7.
117. Heinrich HC. Bioavailability and therapeutic efficiency of oral iron (II)- and -(III) preparations. Schweiz Apotheker-Zeitung 1986;124:1231-56.
118. Shelanski HA. Acute and chronic toxicity tests of carbonyl iron power. Bull Natl Form Comm 1950;18:87-94.
119. Crosby WH. Prescribing iron? Think safety. Arch Intern Med 1978;138:766-7.
120. Wiseman HM, Guest K, Murray VS, Volans GN. Accidental poisoning in childhood - a multicentre survey. 2. The role of packaging in accidents involving medications. Hum Toxicol 1987;6:303-14.
121. Iron-containing supplements and drugs: label warning statements and unit-dose packaging requirements; final rule. Fed Regist 1997;62:2217-50.
122. Tennenbein M. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med 2005;159:557-60.
123. Woolf A, Litovitz T. Progress in the prevention of childhood iron poisoning [editorial]. Arch Pediatr Adolesc Med 2005;159:593-5.
124. Food and Drug Administration, HHS. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order. Fed Regist 2003;68:59714-5.
125. Anderson RV, Tybjag-Hansen A, Appleyard M, Birgens H, Nordestgard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 2004;103:2914-419.
126. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G - >A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
127. Asberg A, Hveen K, Kruger O, Bjerve KS. Person with screening-detected haemochromatosis: as healthy as the general population? Scand J Gastroenterol 2002;37:719-24.
128. Jackson HA, Carter K, Darke C, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001;114:474-84.
129. Wilson JW, Wilkenson-Enns C, Goldman JD, et al. Combined results from USDA's 1994 and 1995 Continuing Survey of Food Intakes by Individuals and 1994 and 1995 Diet and Health Knowledge Survey (Table Set 5) [table on the Internet]. Table 19. Washington (DC): United States Department of Agriculture, Agricultural Research Service; 1997 [accessed 2006 Mar 2]. p. 97. Available from: http://www.ars.usda.gov/SP2UserFiles/Place/12355000/pdf/Tbchts95.PDF
130. Drug information for the health care professional. Vol. I, 25th ed. Greenwood Village (CO): Thompson Micromidex; 2005.
131. Drug facts and comparisons. 59th ed. St Louis (MO). JB Lippincott Co.; 2005.
132. American Hospital Formulary Service (AHFS). Bethesda (MD): American Society of the Health System Pharmacists; 2004.
133. Newman BH. Adjusting our management of female blood donors: the key to an adequate blood supply [invited commentary]. Transfusion 2004;44:591-6.
134. Newman B, Baetens J, Waxman D. Evaluation of a lower hematocrit acceptance level and a yearly limit on the number of female blood donations [abstract]. Transfusion 1997;37(Suppl):24S.
135. Garn SM, Smith NJ, Clark DC. The magnitude and the implications of apparent race differences in hemoglobin values. Am J Clin Nutr 1975;28:563-8.
136. Hoobler IM, Hunscher HA. Hemoglobin differences between blacks and whites. Am J Clin Nutr 1977;30:1935-43.
137. Meyers LD, Habicht JP, Johnson CL. Components of the difference in hemoglobin concentrations in blood between black and white women in the United States. Am J Epidemiol 1979;109:539-49.
138. Garn SM, Ryan AS, Abraham S. The black-white differences in hemoglobin levels after age, sex and income matching. Ecol Food Nutr 1980;10:69-70.
139. Garn SM. Lower hematocrit levels in blacks are not due to diet or socioeconomic factors. Pediatrics 1981;67:580.
140. Castro OL, Haddy TB, Rana SR. Age- and sex-related blood cell values in healthy black Americans. Pub Health Rep 1987;102:232-7.
141. Jackson RT. Separate hemoglobin standards for blacks and whites: a critical review of the case for separate and unequal hemoglobin standards. Med Hypotheses 1990;32:181-9.
142. Pan WH, Habicht JP. The non-iron-deficiency-related difference in hemoglobin concentration distribution between blacks and whites and between men and women. Am J Epidemiol 1991;134:1410-6.
143. Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med 1991;151:501-5.
144. Jackson RT. Hemoglobin comparisons between African American and European American males with hemoglobin values in the normal range. J Hum Biol 1992;4:313-8.
145. Perry GS, Byers T, Yip R, Margen S. Iron nutrition does not account for the hemoglobin differences between blacks and whites. J Nutr 1992;122:1417-24.
146. Johnson-Spear MA, Yip R. Hemoglobin difference between black and white women with comparable iron status: justification for race-specific anemia criteria. Am J Clin Nutr 1994;60:117-21.
147. Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 2005;106:740-5.
148. Fulwood F, Johnson CI, Bryner JD, Gunter EW, McGrath CR. Hematological and nutritional biochemistry reference data for persons 6 months-74 years of age; United States, 1976-1980. Vital and health statistics, Series 11-No 232, CHHS Publication No. (PYS) 83-1682, Tables 22-25. Washington (DC): Public Health Service, National Center for Health Statistics, Government Printing Office; 1982.
149. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration. Blood 2006;107:1747-50.
150. Simon TL. Iron, iron everywhere but not enough to donate [editorial]. Transfusion 2002;42:664-5.